These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6334621)

  • 1. [Corticotropin-releasing factor concentrations in cerebrospinal fluid and its diurnal rhythm in patients with Cushing's disease].
    Yokoe T; Kuwayama A; Ichihara K; Yamamoto N; Kageyama N
    Nihon Naibunpi Gakkai Zasshi; 1984 Aug; 60(8):964-70. PubMed ID: 6334621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders.
    Tomori N; Suda T; Tozawa F; Demura H; Shizume K; Mouri T
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1305-7. PubMed ID: 6605358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatomedin levels in cerebrospinal fluid from adults with pituitary disorders.
    Bäckström M; Hall K; Sara V
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):171-8. PubMed ID: 6388207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.
    Pecori Giraldi F; Invitti C; Cavagnini F;
    Clin Endocrinol (Oxf); 2001 May; 54(5):601-7. PubMed ID: 11380490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective bilateral and simultaneous catheterization of the inferior petrosal sinus: CRF stimulates prolactin secretion from ACTH-producing microadenomas in Cushing's disease.
    Schulte HM; Allolio B; Günther RW; Benker G; Winkelmann W; Ohnhaus EE; Reinwein D
    Clin Endocrinol (Oxf); 1988 Mar; 28(3):289-95. PubMed ID: 2844450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.
    Kling MA; Rubinow DR; Doran AR; Roy A; Davis CL; Calabrese JR; Nieman LK; Post RM; Chrousos GP; Gold PW
    Neuroendocrinology; 1993 Jan; 57(1):79-88. PubMed ID: 8097579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies for clinical application of ovine corticotropin-releasing factor].
    Kubo M
    Hokkaido Igaku Zasshi; 1985 Mar; 60(2):282-98. PubMed ID: 2987091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of immunoreactive corticotropin-releasing factor in human cerebrospinal fluid.
    Suda T; Tozawa F; Mouri T; Demura H; Shizume K
    J Clin Endocrinol Metab; 1983 Jul; 57(1):225-6. PubMed ID: 6602142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating adrenomedullin is increased in patients with corticotropin-dependent Cushing's syndrome due to pituitary adenoma.
    Letizia C; Di Iorio R; De Toma G; Marinoni E; Cerci S; Celi M; Subioli S; D'Erasmo E
    Metabolism; 2000 Jun; 49(6):760-3. PubMed ID: 10877203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease.
    Suda T; Tozawa F; Mouri T; Sasaki A; Shibasaki T; Demura H; Shizume K
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1094-9. PubMed ID: 6302123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACTH response to desmopressin in a patient with acromegaly; expression of corticotropin-releasing factor, urocortins and vasopressin V1b receptor in GH-producing pituitary adenoma.
    Arihara Z; Sakurai K; Osaki Y; Fukazawa H; Yamada S; Inoshita N; Murakami O; Ohba K; Takahashi K
    Endocr J; 2011; 58(12):1029-36. PubMed ID: 21908929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactive corticotropin-releasing factor in human plasma.
    Suda T; Tomori N; Yajima F; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
    J Clin Invest; 1985 Nov; 76(5):2026-9. PubMed ID: 2997301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary.
    Lytras N; Grossman A; Perry L; Tomlin S; Wass JA; Coy DH; Schally AV; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1984 Jan; 20(1):71-84. PubMed ID: 6319053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease.
    Pieters GF; Hermus AR; Smals AG; Bartelink AK; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1983 Sep; 57(3):513-6. PubMed ID: 6308029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
    Grossman AB; Howlett TA; Perry L; Coy DH; Savage MO; Lavender P; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1988 Aug; 29(2):167-78. PubMed ID: 2854761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
    Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma ACTH-response to the corticotropin releasing factor in patients with Cushing's disease. Comparison with the lysine-vasopressin test.
    Catania A; Cantalamessa L; Orsatti A; Mosca G; Minonzio F; Motta P; Reschini E; Zanussi C
    Metabolism; 1984 May; 33(5):478-81. PubMed ID: 6325850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of synthetic corticotropin-releasing factor in normal individuals and in patients with hypothalamic-pituitary-adrenocortical disorders.
    Jørgensen H; Skare S; Frey H; Hanssen KF; Norman N
    Acta Med Scand; 1985; 218(1):79-84. PubMed ID: 2996312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.